First Drug to Treat Common, Lethal Liver Disease Gets US Nod
- 16 Mar 2024
Why is it in the News?
Madrigal Pharmaceuticals Inc.’s drug Rezdiffra gained the first US approval to treat a potentially deadly liver disease that affects millions worldwide, succeeding in an area where some bigger rivals have failed.
What is Nonalcoholic Steatohepatitis (NASH)?
- Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver.
- NASH (or nonalcoholic steatohepatitis) is a type of NAFLD that can damage the liver.
- NASH occurs when the fat buildup in the liver leads to inflammation (hepatitis) and scarring.
- NASH can be life-threatening, as it can cause liver scarring (called cirrhosis) or liver cancer.
- It is estimated that 3% to 5% of the global population is affected by NASH, though the disease is considered to be underdiagnosed.
Who gets NASH?
- The condition may be hereditary.
- If a person has family members who have had NASH or NAFLD, they are at risk.
- Additionally, having certain health conditions may increase a person’s risk of developing NASH. These include:
- Being overweight or obese.
- Having high cholesterol or high triglyceride levels.
- Having type 2 diabetes, insulin resistance, or prediabetes.
What are the signs and symptoms of NASH?
- NASH is known as a “silent” disease because many people present with few or no symptoms.
- However, some people will experience tiredness, pain, and discomfort in the upper right part of the abdomen.
How is NASH diagnosed?
- Diagnosing NASH can be challenging because symptoms may not be noticeable until the disease progresses.
- Healthcare providers typically suspect NASH based on abnormal blood or liver test results or imaging showing liver fat.
- Confirmation requires a liver biopsy, an invasive procedure with risks and expenses, involving taking a small liver sample for microscopic examination.
How is NASH treated?
- To manage NASH, losing weight is often recommended as it can reduce liver fat, inflammation, and scarring.
- This involves losing around 3% to 5% of body weight by limiting fats and sugars in the diet.
- Heavy alcohol use should also be avoided to prevent further liver damage.
- If NASH progresses to cirrhosis, treatment may involve medications, medical procedures, or even a liver transplant.
- Currently, there are no approved medications specifically for treating NASH, but ongoing research aims to develop new treatments.